186 results
Page 4 of 10
8-K
EX-99.1
9gp cd8vd5aqb
22 Apr 20
Entry into a Material Definitive Agreement
8:05am
8-K
EX-99.1
qrovots krxv9gmjyg
30 Mar 20
Cocrystal Pharma Reports 2019 Financial Results and Outlines Expected Value-Driving Milestones for 2020
6:10am
8-K
EX-10.1
ibi4j6mr5bb706w76
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
8-K
EX-99.1
5fh8bnup na9m7t
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
424B5
9dfxb6mkj3rqgujptcm4
10 Mar 20
Prospectus supplement for primary offering
3:04pm
8-K
EX-10.2
e9yg30
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
EX-99.1
9mqbo3y5zuyjv7d
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
EX-10.1
gtbs5wbg32g16yw39 y1
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
424B5
ld3ck4m oejdm
28 Feb 20
Prospectus supplement for primary offering
1:27pm
424B5
ku08ff1
31 Jan 20
Prospectus supplement for primary offering
8:03am
8-K
EX-1.1
ul45 q1sczoxtxm
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
8-K
EX-10.1
knto9r j8a
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
424B5
96rko
31 Jan 20
Prospectus supplement for primary offering
8:01am
424B5
e5z wofgy
31 Oct 19
Prospectus supplement for primary offering
4:05pm
424B5
h4wb syy0g0
31 Oct 19
Prospectus supplement for primary offering
4:02pm
8-K
EX-1.1
xb8vox 309pteewoj09
31 Oct 19
Entry into a Material Definitive Agreement
9:29am
8-K
EX-99.1
0zkvuq27ztq3dvae
30 Oct 19
Cocrystal Pharma, Inc. Announces Proposed Underwritten Public Offering of Common Stock
5:09pm
424B5
gz6md
30 Oct 19
Prospectus supplement for primary offering
4:59pm